Neurothrombectomy Devices Market Report by Product (Clot Retrievers, Aspiration/Suction Devices, Vascular Snares, and Others), End Use (Hospitals and Clinics, Ambulatory Surgical Centers, and Others), and Region 2025-2033

Neurothrombectomy Devices Market Report by Product (Clot Retrievers, Aspiration/Suction Devices, Vascular Snares, and Others), End Use (Hospitals and Clinics, Ambulatory Surgical Centers, and Others), and Region 2025-2033

Report Format: PDF+Excel | Report ID: SR112025A3479

Market Overview:

The global neurothrombectomy devices market size reached USD 733.3 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 1,184.4 Million by 2033, exhibiting a growth rate (CAGR) of 5.03% during 2025-2033.

Report Attribute 
Key Statistics
Base Year
2024
Forecast Years
2025-2033
Historical Years
2019-2024
Market Size in 2024
USD 733.3 Million
Market Forecast in 2033
USD 1,184.4 Million
Market Growth Rate 2025-2033 5.03%


A neurothrombectomy is performed to retrieve or destroy blood clots in the cerebral neurovasculature using laser, mechanical and ultrasound technologies. It is primarily used for rapid achievement of recanalization, and increasing efficiency to treat large vessel occlusions and lowering the risk of hemorrhagic events. It also assists in minimizing the mortality rate among patients and improving functional outcomes. As a result, neurothrombectomy devices are extensively utilized in the treatment of acute ischemic stroke (AIS) across the globe.

According to the World Health Organization (WHO), stroke represents one of the leading causes of dementia and depression across the globe. It results in the sudden death of brain cells on account of the lack of oxygen. As neurothrombectomy devices aid in destroying blood clots, increasing blood supply to the brain and decreasing the mortality rate, the rising instances of AIS, particularly among the geriatric population, are positively influencing the growth of the market. Additionally, due to the rapid product approval process, leading manufacturers are introducing technologically advanced variants. For instance, Medtronic PLC launched its fourth-generation Solitaire X revascularization device in April 2019 for the treatment of AIS. This device features an optimized delivery system for improved efficiency while also retaining the technical features. Similarly, Vesalio obtained Conformite Europeenne (CE) mark approval for NeVa, an advanced neurothrombectomy device, in May 2019 and introduced an optimized delivery system for efficient results. This device relies on the DropZone and Smart Marker technology and features characteristics like a distal filter. Other factors, including the increasing adoption of unhealthy lifestyles and the escalating demand for minimally invasive surgeries by individuals, are anticipated to foster the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global neurothrombectomy devices market report, along with forecasts at the global, regional and country level from 2025-2033. Our report has categorized the market based on product and end use.

Breakup by Product:

  • Clot Retrievers
  • Aspiration/Suction Devices
  • Vascular Snares
  • Others
     

Breakup by End Use:

  • Hospitals and Clinics
  • Ambulatory Surgical Centers
  • Others
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa


Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Acandis GmbH, Shandong Weigao Group Medical Polymer Company Limited, Edwards Lifesciences Corporation, Johnson & Johnson, Koninklijke Philips N.V., Medtronic Plc, Penumbra Inc., Phenox GmbH, Stryker Corporation, Teleflex Incorporated, Terumo Corporation and Vesalio LLC.

Report Coverage:

Report Features Details
Base Year of the Analysis 2024
Historical Period 2019-2024
Forecast Period 2025-2033
Units Million USD
Segment Coverage Product, End Use, Region
Region Covered Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Acandis GmbH, Shandong Weigao Group Medical Polymer Company Limited, Edwards Lifesciences Corporation, Johnson & Johnson, Koninklijke Philips N.V., Medtronic Plc, Penumbra Inc., Phenox GmbH, Stryker Corporation, Teleflex Incorporated, Terumo Corporation and Vesalio LLC
Customization Scope 10% Free Customization
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)


Key Questions Answered in This Report:

  • How has the global neurothrombectomy devices market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global neurothrombectomy devices market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the end use?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global neurothrombectomy devices market and who are the key players?
  • What is the degree of competition in the industry?

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Neurothrombectomy Devices Market Report by Product (Clot Retrievers, Aspiration/Suction Devices, Vascular Snares, and Others), End Use (Hospitals and Clinics, Ambulatory Surgical Centers, and Others), and Region 2025-2033
Purchase Options New Year Sale
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials